Prenetics and Artisan Acquisition Corp. Announce Shareholder Approval of Business Combination, To Begin Trading on Nasdaq on May 18 Under the Ticker “PRE”
Prenetics Reports Record First Quarter 2022 Preliminary Financial Results. Nasdaq Listing in Partnership with Artisan Acquisition Corp. Expected on May 18, 2022
Prenetics and Artisan Announce Effectiveness of Registration Statement and Extraordinary General Meeting Date for Proposed Business Combination.
Prenetics Announces Strong First Half 2021 Financial Results as Company Progresses Towards a U.S. Nasdaq Listing in Partnership with Artisan Acquisition Corp.
Prenetics to be the Exclusive RT-PCR COVID-19 Testing Partner for the Standard Chartered Hong Kong Marathon 2021.
Prenetics, a Global Leader in Genomic and Diagnostic Testing, to Become Publicly-Traded on the Nasdaq via Merger with Adrian Cheng’s Artisan Acquisition Corp.